Stay updated with breaking news from Sight Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study is first of its kind to explore the impact of LHON on patients and their relatives in four different countries Study determined that the impact of LHON extends beyond vision-related
Sustained demand of LUMEVOQ ATUs in France generating €3.1 million revenues in Q1 2022 €36.0 million of cash as of March 31, 2022; runway confirmed to early Q1 2023 Regulatory News: GenSight
New submission date for Day 120 responses: October 2022 Restart of validation batches in Q3 2022 Committee for Medicinal Products for Human Use (CHMP) opinion expected by Q3 2023 Regulatory
Light can be used to stimulate light-sensitive receptors in order to turn brain cells “on” and “off” at the flip of a switch,...
PARIS--(BUSINESS WIRE)--Dec 14, 2021--